Pure Global
NCT04411732

Myotonia and Muscle Stiffness in NMD

Myotonia, Muscle Stiffness and Elasticity in Neuromuscular Disorders
LMU Klinikum·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Neuromuscular Disorders
Drug/Device/Intervention
MyotonPro
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
LMU Klinikum
Location
Munich, Germany
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2019
End date
Mar 31, 2023
Enrollment
90 participants
Primary outcome

MyotonPro device in patients with dystrophic and non-dystrophic myotonia

Summary

The primary objective of this study is to assess stiffness, muscle tone, relaxation periods
 and elasticity of various muscles in patients with dystrophic or non-dystrophic myotonia. The
 secondary objectives are (1) to provide reference values for stiffness, muscle tone,
 relaxation periods and elasticity of various muscles in patients with dystrophic or
 non-dystrophic myotonia; to provide reference values for stiffness, muscle tone, relaxation
 periods and elasticity of various muscles in patients with non-myotonic neuromuscular
 disorders, (3) assess correlations between to compare result values for stiffness, muscle
 tone, relaxation periods and elasticity with clinical muscle function tests, measured by
 clinical evaluation (MRC-scale) and the 6-minute walk test; (4) assess correlations between
 subcutaneous fat and muscle thickness and echogenicity, measured by muscle ultrasound and
 result values for stiffness, muscle tone, relaxation periods and elasticity.

ICD-10 classifications
Other disorders of muscleDisorders of musclesOther specified disorders of musclePrimary disorders of musclesOther primary disorders of muscles
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04411732
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT04411732 through Pure Global AI's free database. This phase not specified trial is sponsored by LMU Klinikum and is currently Recruiting. The study focuses on Neuromuscular Disorders. Target enrollment is 90 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.